Abstract
Abuse of physician prescribed opioids contributes to health and economic burdens associated with dependency, overdose, and death. Since the 1900s, the United States (U.S.) Congress has legislated use and misuse of controlled substances. Under the U.S. Constitution, states developed prescription drug monitoring programs (PDMPs) that determine how the program is managed, what data to track, and what information to share with other states. Lack of a standard data set that allows providers to see prescribing data for designated controlled substances across state lines, limits benefits of state PDMPs. A federal PDMP with a standard minimal set of variables shared across states could enhance patient care. States would exercise their police powers while sharing standard data to decrease adverse consequences of the opioid epidemic.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dart RC, Severtson SG, Bucher-Bartelson B. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(16):1573–4.
Florence CLF, Rice K. The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug Alcohol Dependency. 2021;218:108350.
Shepherd J. Combating the prescription painkiller epidemic: a national prescription drug reporting program. Am J Law Med. 2014;40(1):85–112.
Brat GA, Agniel D, Beam A, Yorkgitis B, Bicket M, Homer M, et al. Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study. BMJ. 2018;360:j5790.
Seyler T, Giraudon I, Noor A, Mounteney J, Griffiths P. Is Europe facing an opioid epidemic: what does European monitoring data tell us? Eur J Pain. 2021;25(5):1072–80.
van Amsterdam J, Pierce M, van den Brink W. Is europe facing an emerging opioid crisis comparable to the U.S.? Ther Drug Monit. 2021;43(1):42–51.
Understanding the Opioid Overdose Epidemic: Centers for Disease Control and Prevention; 2021. https://www.cdc.gov/opioids/basics/epidemic.html. Accessed 17 March 2021
Leveraging prescription drug monitoring program (PDMP) data in overdose prevention and response. In: Control NCfIPa, editor. Centers for Disease Control and Preventon; 2021. p. 33.
Levy N, Sturgess J, Mills P. “Pain as the fifth vital sign” and dependence on the “numerical pain scale” is being abandoned in the US: why? Br J Anaesth. 2018;120(3):435–8.
Davis CS. The purdue pharma opioid settlement—accountability, or just the cost of doing business? N Engl J Med. 2021;384(2):97–9.
Lyapustina T, Rutkow L, Chang H-Y, Daubresse M, Ramji AF, Faul M, et al. Effect of a “pill mill” law on opioid prescribing and utilization: the case of Texas. Drug Alcohol Depend. 2015;159:190–7.
Guy G, Zhang, K.. Vital signs: changes in opioid prescribing in the United States, 2006–2015: Centers for Disease Control and Prevention; 2017. http://www.cdc.gov/mmwr.volumes/66/wr/mm6626a4.htm.
Federal Food and and Drugs Act, (1906).
Kenny BJ, Preuss CV, Zito PM. Controlled Substance Schedules. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright © 2022, StatPearls Publishing LLC; 2022.
Barnes MC, Arndt G. The best of both worlds: applying federal commerce and state police powers to reduce prescription drug abuse. J Health Care Law Policy. 2013;16(2):271–307.
State v. Gee. 236 P2d 1029: Arizona Supreme Court; 1951. p. 1029.
Sacco L, Duff, JH, Sarata, AK. Prescription drug monitoring programs. In: Service CR, editor. Washington: Congressioal Research Service; 2018.
Wen K, Johnson P, Jeng PJ, Schackman BR, Bao Y. State policies for prescription drug monitoring programs and adverse opioid-related hospital events. Med Care. 2020;58(7):610–6.
Worley J. Prescription drug monitoring programs, a response to doctor shopping: purpose, effectiveness, and directions for future research. Issues Ment Health Nurs. 2012;33(5):319–28.
Lin H-C, Wang Z, Simoni-Wastila L, Boyd C, Buu A. Interstate data sharing of prescription drug monitoring programs and associated opioid prescriptions among patients with non-cancer chronic pain. Prev Med. 2019;118:59–65.
Martins SS, Ponicki W, Smith N, Rivera-Aguirre A, Davis CS, Fink DS, et al. Prescription drug monitoring programs operational characteristics and fatal heroin poisoning. Int J Drug Policy. 2019;74:174–80.
PDMP Policies and Practices: Prescription Drug Monitoring Program Training and Technical Assistance Center; 2022. https://www.pdmpassist.org/pdf/Mandatory_Query_Conditions.pdf. Accessed 21 Oct 2022.
Interstate PDMP Access and Data Sharing Alignment. Prescription Drug Monitoring Program Training and Technical Assistance Center; 2021 January, 2021.
Funding
There is no funding associated with this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Pehrson, A., Solla, C.A., Buehler, J. et al. A prescription drug monitoring program, data sharing, and upholding states’ rights under the United States Constitution. J Public Health Pol 44, 102–109 (2023). https://doi.org/10.1057/s41271-022-00385-3
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1057/s41271-022-00385-3